The AMDS Hybrid Prosthesis was designed to help clinicians treat DeBakey Type 1 dissections complicated by malperfusion. It works as a complement to hemiarch replacement, preserving the native arch and making reinterventions possible if needed. 

The recall includes a total of nearly 45,000 devices that should be returned to the manufacturer.

New Neiman research explores how Medicare's New Technology Add-On Payment has impacted use of an AI triage tool for pinpointing severe strokes.